At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine prevention.

In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to ...

Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, Ocugen, and Pfizer.

Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

Worldwide Clinical Trials (Worldwide) has introduced a new AI-driven tool for improving optimisation of studies.

The trial is expected to enrol 48 subjects with amyotrophic lateral sclerosis across North America. Credit: David Herraez Calzada/Shutterstock. Amylyx Pharmaceuticals has dosed the first subject in ...

Annual Meeting Clinical Trials Plenary Session, Sanofi presented data on tolebrutinib in patients with non-relapsing ...

MaaT Pharma has reported positive results from an interim safety analysis of its Phase IIb trial of MaaT033 in subjects ...

After dropping the FNAIT therapy, Rallybio will prioritise another candidate that is being investigated in complement-driven diseases.

LifeMine Therapeutics has dosed the first subject in the Phase I trial of calcineurin inhibitor (CNi), LIFE-001.

Scientist.com has launched a new tool, Clinical Labs Navigator, for sourcing, managing, and executing services for clinical ...

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...